Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,181.0
-17.6 (-0.55%)

 

  • STI Straits Times Index
    3,181.0
    -17.6 (-0.55%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,531.2
    -3.8 (-0.25%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,308.8
    -300.3 (-1.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,039.7
    9.5 (0.31%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,386.7
    -92.4 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,882.3
    -60.2 (-1.01%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,078.9M
  • Value: 1,171.0M
  • Rise: 88
  • Fall: 225
  • Unch: 501

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AusGroup^0.048-0.004
Rex Intl0.193-0.007
Ntegrator Intl0.008-0.002
Medtecs Intl0.097+0.001
Ley Choon0.019+0.001
YZJ Shipbldg SGD1.040-
Singtel3.100-0.030
ComfortDelGro2.020-0.030
Genting Sing0.880-
Dyna-Mac0.134-0.016

World Indices

World Indices
Name Last Change
Nasdaq 9,751.0 -66.2
HSI 27,308.8 -300.4
HSCEI 10,790.8 -123.1
Jakarta 5,882.3 -60.2
Nikkei 225 23,386.7 -92.4
SSE Comp 3,039.7 +9.5
Shanghai A 3,185.3 +10.0
Shanghai B 244.9 +0.8
KOSPI 2,162.8 -32.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

News - Detailed News Story

AsiaMedic: Change - Announcement of Appointment :: APPOINTMENT OF CHIEF OPERATING OFFICER

10 Jan 2020 23:47

Change - Announcement of Appointment :: APPOINTMENT OF CHIEF OPERATING OFFICER

Announcement Title Change - Announcement of Appointment
Date & Time of Broadcast Jan 10, 2020 23:47
Status New
Announcement Sub Title APPOINTMENT OF CHIEF OPERATING OFFICER
Announcement Reference SG200110OTHRWWAB
Submitted By (Co./ Ind. Name) Stanley Woo
Designation Group Financial Controller
Description (Please provide a detailed description of the event in the box below) This announcement has been reviewed by the Company's sponsor, Xandar Capital Pte Ltd, in compliance with Rule 226 of the Rules of Catalist. It has not been examined or approved by the Singapore Exchange Securities Trading Limited ("SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Pauline Sim (Registered Professional, Xandar Capital Pte Ltd) at 3 Shenton Way, #24-02 Shenton House, Singapore 068805. Telephone number: (65) 63194954.
Additional Details
Date Of Appointment 01/01/2020
Name Of Person Dr Wong Kae Thong
Age 43
Country Of Principal Residence Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) Dr Wong Kae Thong was appointed Acting Chief Operating Officer on 8 April 2019.

The Nominating Committee has reviewed the credentials, experience and performance of Dr Wong and recommended her
appointment as Chief Operating Officer. The Board of Directors has accepted and approved her appointment based on the recommendation of the Nominating Committee.

The offer to appoint Dr Wong as Chief Operating Officer was made by the Company in December 2019. She formally accepted the appointment on 10 January 2020.
Whether appointment is executive, and if so, the area of responsibility The appointment is executive.

Reporting to the Board of Directors, responsible for managing day-to-day matters such as business development, operations and corporate matters to achieve the Group's goals and objectives.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Chief Operating Officer
Professional qualifications Dr Wong is a general practitioner with special interests in preventive medicine, palliative medicine, women's and children's health. She graduated from the University of Western Ontario, Canada.
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries No
Conflict of interests (including any competing business) No
Working experience and occupation(s) during the past 10 years Dr Wong joined AsiaMedic Wellness Assessment Centre Pte Ltd as Medical Officer in 2007 and has been with the Group ever since. She was the Medical Director of AsiaMedic Wellness Assessment Centre Pte Ltd and the General Manager of Complete Healthcare International Pte Ltd.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6)) Yes
Shareholding interest in the listed issuer and its subsidiaries? No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years) Nil
Present Nil
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? No
(c) Whether there is any unsatisfied judgment against him? No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? No
Any prior experience as a director of an issuer listed on the Exchange? No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange Not an appointment of director
Source: SGXNet
Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.